Alemtuzumab News and Research

RSS
Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers

Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

CAM314 randomized Phase 3 clinical trial results released

CAM314 randomized Phase 3 clinical trial results released

Less expensive anti-rejection drug as effective as more expensive drug, says study

Less expensive anti-rejection drug as effective as more expensive drug, says study

Phase 2 MS clinical trial data continues to show durable reductions in relapse rate

Phase 2 MS clinical trial data continues to show durable reductions in relapse rate

New treatment strategies for multiple sclerosis

New treatment strategies for multiple sclerosis

Monoclonal antibody cancer therapy

Monoclonal antibody cancer therapy

Azaya Therapeutics selected for Nanotechnology Characterization Lab by National Cancer Institute

Azaya Therapeutics selected for Nanotechnology Characterization Lab by National Cancer Institute

Novel concept in chronic lymphoid leukemia treatment

Novel concept in chronic lymphoid leukemia treatment

Leukaemia drug may reverse multiple sclerosis brain damage

Leukaemia drug may reverse multiple sclerosis brain damage